RecruitingNCT04274283

Tessa Jowell BRAIN MATRIX - Platform Study

A British Feasibility Study of Molecular Stratification and Targeted Therapy to Optimize the Clinical Management of Patients With Glioma by Enhancing Clinical Outcomes, Reducing Avoidable Toxicity, Improving Management of Post-operative Residual & Recurrent Disease and Improving Survivorship


Sponsor

University of Birmingham

Enrollment

1,000 participants

Start Date

Nov 24, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The main aim of the Tessa Jowell BRAIN MATRIX - Platform Study is to more precisely determine the exact type of tumour patients have by developing the essential infrastructure to provide rapid and accurate molecular diagnosis. A large network of clinical hubs across the United Kingdom, with expertise in managing patients with brain tumours, will be developed. Once established this infrastructure will facilitate the rapid introduction of clinical trials testing targeted therapies tailored to the genetic changes of an individual's tumour.


Eligibility

Min Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This is a large UK platform study for people with brain tumors called gliomas. It uses advanced genetic testing of tumors to match patients to the most appropriate treatments and to better understand how these brain cancers work. It is designed to test multiple approaches at once. **You may be eligible if...** - You have been newly diagnosed with a glioma (a type of brain tumor, grade 2-4) confirmed by imaging - You are able to have a surgical procedure to get a tumor sample - You have a previously diagnosed glioma that has come back or progressed - You have given written informed consent **You may NOT be eligible if...** - Your tumor is in the spinal cord rather than the brain - You are actively being treated for another cancer at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMatched Tumour and Blood Sample - Research Pathway

For patient's undergoing surgery fresh tissue will be collected from the initial surgery and frozen until shipment to the Oxford BRAIN MATRIX Lab. Matched blood sample for germline DNA will be taken post-Platform Study entry. For patients with progression with available tumour samples from previous tumour surgery, blood will be collected and sent to Oxford along with their tumour samples. Samples will be shipped together to Oxford for molecular analysis (Whole Genome Sequencing (WGS) and EPIC array). The BRAIN MATRIX neuropathology and genomics team will produce an integrated report (histology, WGS, Heidelberg Classifier) for each case in consultation with the local neuropathology team. Once data is available, a virtual MDT with the BRAIN MATRIX neuropathology, genomics team and local site will be held to ensure all relevant information is incorporated in the final BRAIN MATRIX diagnostic report. The resulting integrated histological-molecular report will be available to local sites

OTHERMatched Tumour and Blood Sample - NHS GMS pathway

Tessa Jowell BRAIN MATRIX centres in England can submit matched tissue and blood samples for Whole Genome Sequencing through the standard of care NHS Genomic Medicine Service pathway via their Genomic Laboratory Hub. For those from Devolved Nations, samples must go to the Oxford BRAIN MATRIX Laboratory who can facilitate the processing of samples through an alternative NHS GMS GLH or via the research pathway.


Locations(14)

Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust

Birmingham, United Kingdom

Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust

Cambridge, United Kingdom

Velindre Cancer Centre, Velindre University NHS Trust

Cardiff, United Kingdom

NHS Lothian

Edinburgh, United Kingdom

Queen Elizabeth Unviersity Hospital, NHS Greater Glasgow and Clyde Health Board

Glasgow, United Kingdom

St James's University Hospital, Leeds Teaching Hospitals NHS Trust

Leeds, United Kingdom

The Walton Centre, The Walton Centre NHS Foundation Trust

Liverpool, United Kingdom

King's College Hospital, King's College Hospital NHS Foundation Trust

London, United Kingdom

Charing Cross Hospital, Imperial College Healthcare NHS Trust

London, United Kingdom

The Christie Hospital, The Christie NHS Foundation Trust

Manchester, United Kingdom

Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust

Manchester, United Kingdom

Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust

Newcastle upon Tyne, United Kingdom

Queen's Medical Centre, Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

Churchill Hospital, Oxford University Hospitals NHS Foundation Trust

Oxford, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04274283


Related Trials